BlossomHill Therapeutics, Inc. (BLSM) vs Climb Bio, Inc. (CLYM)

A side-by-side comparison of BlossomHill Therapeutics, Inc. and Climb Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BlossomHill Therapeutics, Inc. logo
BLSM
BlossomHill Therapeutics, Inc.
$580M
$19.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Climb Bio, Inc. logo
CLYM
Climb Bio, Inc.
$633M
$11.05HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BLSM vs CLYM

growth of $100 · dividends reinvested · last 1y
BLSM +24.6% (+24.6%/yr)CLYM -21.1% (-21.1%/yr)BLSM compounded faster over this window
80100120140160Start $100$125$79
BLSM CLYM

BLSM vs CLYM: by the numbers

  • •CLYM is the larger company ($633M vs $580M market cap).

Metrics side by side

Valuation

MetricBLSMCLYM
P/B ratioN/A2.64

Profitability

MetricBLSMCLYM
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-24.06%
ROIC-43.41%-26.94%

Go deeper

Full BLSM analysisFull CLYM analysisInteractive comparison tool

Dig into the metrics

BlossomHill Therapeutics ROEClimb Bio ROEBlossomHill Therapeutics operating marginClimb Bio operating marginBlossomHill Therapeutics revenue growthClimb Bio revenue growthBlossomHill Therapeutics free cash flowClimb Bio free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.